CoRISMA MCS Systems Inc. logo — Next Generation Heart Assist Therapy

CoRISMA MCS Systems Inc.

Next Generation Heart Assist Therapy

Founded 2018 United States Hamden, United States 6 employees Series A Total: $27.00M Health Care, Health and Wellness +1

General Information

Company Name CoRISMA MCS Systems Inc.
Founded Year 2018
Location United States Hamden, United States +1
Employees 6
Industries Health Care, Health and Wellness, Life Sciences
Funding Stage Series A
Social

Get notified when CoRISMA MCS Systems Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CoRISMA MCS Systems Inc.

Corisma is a United States based startup with the goal of developing a Next Generation Heart Assist Therapy device for advanced heart failure treatment. The company was founded in 2018 and operates within the Health Care industry. The latest boost for Corisma came in the form of a $27.00M Series A investment on 30 August 2021. This investment was made by China Grand Pharmaceutical and Healthcare Holdings, underlining the company's capacity to attract significant attention from reputable international investors. The specialized focus on cardiac health and the backing of prominent investors position Corisma as a compelling prospect for venture capital firms seeking to invest in pioneering medical technology. This successful funding round reflects the potential of Corisma's innovative approach to addressing a critical aspect of healthcare, making it a venture worth keeping a close eye on in the ever-evolving health tech landscape.

Taxonomy: Heart Failure Treatment, Catheter Implantation, Healthcare Innovation, Cardiovascular Medicine, Biomedical Engineering, Yale University, Invasive Therapy, Class 3 Heart Failure, Class 4 Heart Failure, Cardiac Assist Device, Prototype Testing, Grant Funding, Quality of Life Improvement, Cost Reduction

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $27.00M 1 30 Aug 2021
Seed Round Unknown - 11 Jun 2020

CoRISMA MCS Systems Inc. Alternatives & Competitors

CoRISMA MCS Systems Inc. vs

Interceptive therapies for the treatment of heart failure subpopulations

Series A
24 employees
Biotechnology, Health and Wellness
CoRISMA MCS Systems Inc. vs
Alleviant Medical
Alleviant Medical United States

Treatment for chronic heart failure

Series Unknown
49 employees
Biotechnology, Health Care
CoRISMA MCS Systems Inc. vs

Driven by expertise in heart health, our team pioneers innovative therapies targeting mitochondrial...

Biotechnology, Health Care

FAQ About CoRISMA MCS Systems Inc.

Next Generation Heart Assist Therapy
CoRISMA MCS Systems Inc. was founded in 2018.
CoRISMA MCS Systems Inc. is headquartered in Hamden, United States.
CoRISMA MCS Systems Inc. operates in the following industries: Health Care, Health and Wellness, Life Sciences.
CoRISMA MCS Systems Inc. has approximately 6 employees.
CoRISMA MCS Systems Inc. has completed 2 funding rounds, raising a total of $27.00M. The latest funding stage is Series A.
Top alternatives and competitors to CoRISMA MCS Systems Inc. include Corteria Pharmaceuticals, Alleviant Medical, ViCardia, Magenta Medical Ltd., Pumpinheart. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CoRISMA MCS Systems Inc. and Corteria Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CoRISMA MCS Systems Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy